MORPHINANVERBINDUNGEN

Patent europeic · EP3632916 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3632916
Numer da la dumonda
EP19201663
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
30-04-2008
Publitgà
08-04-2020
Concedì
08-06-2022
Stritgà
23-11-2023
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 471/08 (2006.01)
C07B 59/00 (2006.01)
A61K 31/439 (2006.01)
A61P 11/14 (2006.01)
Prioritad
US 91513007 P 01.05.2007
US 91666207 P 08.05.2007
US 97604407 P 28.09.2007
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-11-2023

    Stritgà, taxa betg pajada

    Published in Swissreg on 23.11.2023

  2. 19-04-2023

    Midada

    Published in Swissreg on 19.04.2023

  3. 08-06-2022

    Concedì

    Published in Swissreg on 08.06.2022

Partidas

Possessur

Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals Inc.

99 Hayden Avenue, Suite 500, Lexington, MA 02421, US

Inventur

TUNG, Roger

Lexington, MA Massachusetts 02420, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.